Skip to Main Content

Paper Details

Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention.
JACC Cardiovasc Interv
2
2023
Aspirin, Dyspnea, Patients, Ticagrelor, aspirin, dyspnea, hypercholesterolemia, myocardial infarction, obesity, patients, peripheral artery disease, stroke, ticagrelor
Author NameAffiliation
Samantha SartoriThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
Usman BaberThe University of Oklahoma Health Sciences Center
David J CohenCardiovascular Research Foundation, USA St. Francis Hospital
Erik Magnus OhmanDuke University Medical Center-Duke Clinical Research Institute
Roxana MehranThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 5

Datasets

Release 1.2